Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Infliximab
Page 1 of 2 ( 82 items )
<<
1
2
>>
1
Endometrial stromal sarcoma in a patient with ulcerative colitis receiving immunosuppressive therapy: A case report and review of literature
12/16/2025 6:42:01 AM |
Browse: 27 |
Download: 69
2
Expanding the role of radiomics and artificial intelligence in the management of inflammatory bowel disease: Insights, opportunities, and challenges
11/13/2025 6:51:08 AM |
Browse: 30 |
Download: 90
3
Correlation between radiomic features of Crohn's disease and secondary loss of response to infliximab
7/21/2025 9:42:33 AM |
Browse: 72 |
Download: 370
4
Longitudinal computed tomography-based delta-radiomics of visceral adipose tissue predicts infliximab secondary loss of response in Crohn’s disease patients
6/6/2025 3:09:39 AM |
Browse: 107 |
Download: 625
5
Evaluation of biological therapies in autoimmune hepatitis: A case-based systematic review
3/18/2025 4:25:39 AM |
Browse: 113 |
Download: 475
6
Navigating treatment resistance: Janus kinase inhibitors for ulcerative colitis
7/11/2024 9:22:47 AM |
Browse: 216 |
Download: 617
7
Upadacitinib for refractory ulcerative colitis with primary nonresponse to infliximab and vedolizumab: A case report
3/25/2024 8:14:32 AM |
Browse: 149 |
Download: 739
8
Long-term outcome of stem cell transplantation with and without anti-tumor necrotic factor therapy in perianal fistula with Crohn’s disease
3/25/2024 2:43:27 AM |
Browse: 267 |
Download: 1154
9
Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis
2/25/2024 3:12:20 PM |
Browse: 268 |
Download: 1130
10
Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology
7/27/2023 1:26:07 AM |
Browse: 200 |
Download: 856
11
Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn’s disease
5/11/2023 8:05:04 AM |
Browse: 301 |
Download: 898
12
Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adults
4/24/2023 11:14:10 AM |
Browse: 397 |
Download: 1116
13
Pulmonary cryptococcosis after immunomodulator treatment in patients with Crohn’s disease: Three case reports
1/20/2023 1:48:21 PM |
Browse: 536 |
Download: 1838
14
Multidisciplinary treatment of a patient with severe immune checkpoint inhibitor-induced colitis: A case report
12/14/2022 7:20:14 AM |
Browse: 330 |
Download: 1110
15
Tumor necrosis factor-α inhibition restores matrix formation by human adipose-derived stem cells in the late stage of chondrogenic differentiation
11/25/2022 11:36:34 AM |
Browse: 516 |
Download: 1373
16
Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease
8/10/2022 8:23:14 AM |
Browse: 591 |
Download: 2336
17
How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study
7/27/2022 2:48:54 AM |
Browse: 627 |
Download: 1716
18
Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis
6/17/2022 3:19:26 AM |
Browse: 615 |
Download: 1892
19
Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients
5/13/2022 8:46:12 AM |
Browse: 579 |
Download: 1601
20
Differential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review
12/29/2021 9:44:51 AM |
Browse: 578 |
Download: 1175
21
Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease
12/23/2021 2:14:14 PM |
Browse: 594 |
Download: 2304
22
Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of literature
11/22/2021 10:34:53 AM |
Browse: 694 |
Download: 1493
23
Hemorrhagic pericardial effusion following treatment with infliximab: A case report and review of literature
8/31/2021 6:51:26 AM |
Browse: 593 |
Download: 1161
24
Approach to medical therapy in perianal Crohn’s disease
7/6/2021 2:31:17 AM |
Browse: 651 |
Download: 1156
25
Infliximab treatment of glycogenosis Ib with Crohn's -like enterocolitis: A case report
6/24/2021 7:26:33 AM |
Browse: 640 |
Download: 1676
26
Maintenance treatment with infliximab for ulcerative ileitis after intestinal transplantation: A case report
6/24/2021 7:26:33 AM |
Browse: 582 |
Download: 2050
27
Recalcitrant paradoxical pustular psoriasis induced by infliximab: Two case reports
5/11/2021 11:07:20 AM |
Browse: 568 |
Download: 1499
28
Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report
4/22/2021 12:14:43 PM |
Browse: 642 |
Download: 1901
29
Crohn's disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report
4/9/2021 8:11:26 AM |
Browse: 786 |
Download: 1981
30
Predictive value of biologic blood concentration on endoscopic inactivity in inflammatory bowel disease: A systematic review
3/3/2021 10:02:01 AM |
Browse: 813 |
Download: 2228
31
Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report
12/14/2020 8:10:05 AM |
Browse: 1000 |
Download: 2125
32
First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus
11/20/2020 4:04:17 AM |
Browse: 1021 |
Download: 2424
33
Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn’s disease in China
11/6/2020 7:36:12 AM |
Browse: 922 |
Download: 2783
34
Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability
9/24/2020 6:20:22 AM |
Browse: 1017 |
Download: 2735
35
Management of pembrolizumab-induced steroid refractory mucositis with infliximab: A case report
9/22/2020 3:17:13 AM |
Browse: 953 |
Download: 1564
36
Severe steroid refractory gastritis induced by Nivolumab: A case report
4/28/2020 8:04:31 AM |
Browse: 1099 |
Download: 2323
37
Optimized timing of using infliximab in perianal fistulizing Crohn's disease
4/14/2020 12:30:24 PM |
Browse: 944 |
Download: 2013
38
Crohn’s-like acute severe colitis associated with Hermansky-Pudlak syndrome: A case report
2/27/2019 4:11:15 AM |
Browse: 1262 |
Download: 2083
39
Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report
1/21/2019 9:20:19 AM |
Browse: 1402 |
Download: 1930
40
Biosimilars in paediatric inflammatory bowel disease
9/20/2018 2:33:54 AM |
Browse: 1324 |
Download: 1733
41
Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting
2/2/2018 8:28:46 AM |
Browse: 1241 |
Download: 2131
42
Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy
9/14/2017 3:13:08 AM |
Browse: 1178 |
Download: 1700
43
Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature
8/1/2017 12:23:47 AM |
Browse: 1330 |
Download: 2192
44
Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study
6/14/2017 9:25:57 AM |
Browse: 1327 |
Download: 2665
45
Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study
5/4/2017 8:16:34 AM |
Browse: 1081 |
Download: 1820
46
Combination therapy for inflammatory bowel disease
5/4/2017 8:16:34 AM |
Browse: 1367 |
Download: 2087
47
Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis
3/19/2017 6:44:00 PM |
Browse: 1319 |
Download: 2856
48
Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
2/26/2017 6:20:00 PM |
Browse: 1365 |
Download: 3032
49
Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies
1/5/2017 11:10:00 AM |
Browse: 1123 |
Download: 2229
50
Infliximab does not increase colonic cancer risk associated to murine chronic colitis
11/26/2016 6:56:00 PM |
Browse: 1311 |
Download: 2530
Page 1 of 2 ( 82 items )
<<
1
2
>>
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345